Philip Adamson
Net worth: 31 125 $ as of 31/05/2026
Net worth: 31 125 $ as of 31/05/2026
Philip B. Adamson is currently Chief Medical Officer at CVRx, Inc. since 2024.
Formerly, Dr. Adamson was Chief Medical Officer-Heart Failure Division at Abbott Laboratories from 2015 to 2024 and VP & Medical Director-Heart Failure Therapies at St. Jude Medical LLC from 2015 to 2017.
Education includes graduate studies at the University of Oklahoma and a doctorate from the University of Oklahoma College of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CVRX, INC. 0.02% | 06/04/2026 | 5,578 ( 0.02% ) | 31 125 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CVRX, INC. | Chief Tech/Sci/R&D Officer | 23/05/2024 |
| Companies | Position | End |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/05/2024 |
| ST JUDE MEDICAL INC | Corporate Officer/Principal | 01/01/2017 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
St. Jude Medical LLC
St. Jude Medical LLC Medical SpecialtiesHealth Technology Develops, manufactures and distributes cardiovascular medical devices | Health Technology |
University of Oklahoma
University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
University of Oklahoma College of Medicine
University of Oklahoma College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions